Purifloh Ltd
ASX:PO3
Purifloh Ltd
ASX:PO3
Price:
0.22
AUD
Market Closed
Market Cap:
AU$7.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Purifloh Ltd
ASX:PO3
|
AU |
|
T
|
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
|
CN |
|
S
|
Symbiox Investment & Trading Co Ltd
BSE:539278
|
IN |
|
T
|
Top Ships Inc
AMEX:TOPS
|
GR |
|
C
|
Cogna Educacao SA
OTC:COGNY
|
BR |
|
S
|
Shandong Gold Phoenix Co Ltd
SSE:603586
|
CN |
Balance Sheet
Balance Sheet Decomposition
Purifloh Ltd
Purifloh Ltd
Balance Sheet Decomposition is not available for
Purifloh Ltd
Purifloh Ltd
Balance Sheet
Purifloh Ltd
Purifloh Ltd
Currency: AUD
| Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
6
|
2
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
6
|
2
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
6
|
2
|
0
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
-17%
|
0
-69%
|
0
+1 689%
|
6
+3 823%
|
2
-62%
|
0
-94%
|
0
-28%
|
0
-4%
|
0
-18%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
2
|
2
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
2
|
|
| Total Current Liabilities |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
+35%
|
1
+26%
|
1
-46%
|
1
+42%
|
1
+18%
|
1
+28%
|
2
+82%
|
3
+22%
|
4
+17%
|
|
| Equity | |||||||||||
| Common Stock |
73
|
73
|
73
|
75
|
84
|
84
|
84
|
84
|
85
|
85
|
|
| Retained Earnings |
74
|
74
|
74
|
75
|
78
|
83
|
86
|
87
|
87
|
87
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
1
-38%
|
1
-29%
|
0
+60%
|
5
N/A
|
1
-75%
|
1
N/A
|
2
-95%
|
3
-24%
|
3
-18%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
-17%
|
0
-69%
|
0
+1 689%
|
6
+3 823%
|
2
-62%
|
0
-94%
|
0
-28%
|
0
-4%
|
0
-18%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
21
|
21
|
21
|
27
|
31
|
31
|
32
|
32
|
32
|
32
|
|
Switch to:
Switch to:
See Also
Discover More
